Study2022Open access

Diversity in blueberry genotypes and developmental stages enables discrepancy in the bioactive compounds, metabolites, and cytotoxicity

Das PR, Darwish AG, Ismail A, Haikal AM, Gajjar P, Balasubramani SP, Sheikh MB, Tsolova V, Soliman KFA, Sherif SM, El-Sharkawy I

Food chemistry · 19 citations

How it was studied

Design
In vitro/mechanistic study (classified by our AI screen)
Studied in
Cells or lab samples
Main outcome
No health outcome

Who paid for it

Funding
Independent funding
Government
U.S. Department of Agriculture
Government
National Institute of Food and Agriculture
University or hospital
Fakultät für Geowissenschaften, Geographie und Astronomie, Universität Wien
Government
National Institute on Minority Health and Health Disparities
Government
NIMHD NIH HHS
Grants
National Institute on Minority Health and Health Disparities (U54 MD 007582); National Institute of Food and Agriculture (1021741); National Institute of Food and Agriculture (2020-38821-31086)

Based on 5 listed funder(s).

Publication

Published
2021-11-18 · Food Chem · vol. 374 · p. 131632
Publisher
Elsevier BV
Cited
48 citations · more than 90% of similar papers · 2.4× the field average
Impact
Top 10% most cited in its field
References
43 works
Access
Open access (hybrid journal) · CC-BY-NC-ND
Research areas
Phytochemicals and Antioxidant Activities · Plant Gene Expression Analysis · Plant biochemistry and biosynthesis
Keywords
Nutraceutical, Quinic acid, Chlorogenic acid, Metabolite, Cultivar, Metabolomics, Malic acid, Biology, Ellagic acid, Primary metabolite, Food science, Chemistry, Antioxidant, Biochemistry, Botany, Polyphenol, Citric acid, Chromatography
MeSH
caco-2 cells, humans, phenols, antioxidants, genotype, blueberry plants

11 authors

From US, EG

  • Protiva Rani DasFlorida Agricultural and Mechanical University; Virginia Tech
  • Ahmed G. DarwishFlorida Agricultural and Mechanical University; Minia University
  • Ahmed IsmailDamanhour University; Florida Agricultural and Mechanical University
  • Amr M. HaikalDamanhour University
  • Pranavkumar GajjarFlorida Agricultural and Mechanical University
  • Subramani Paranthaman BalasubramaniAlbany State University; Florida Agricultural and Mechanical University

Abstract

Eight blueberry cultivars at three developmental stages were investigated for metabolite profiling, antioxidant, and anticancer activities. Cultivars- and developmental stages-variations were determined in total phenolic, flavonoid, DPPH, and FRAP antioxidant assays. The anticancer capacity was equal against A549, HepG2, and Caco-2 cancer cells, whereas the inhibition rate was dose-, incubation period-, cultivar-, and developmental stages-dependent. The untargeted metabolite profiling by UPLC-TOF-MS analysis of two contrast cultivars, 'Vernon' and 'Star', throughout the developmental stages revealed 328 metabolites; the majority of them were amino acids, organic acids, and flavonoids. The multivariate statistical analysis identified five metabolites, including quinic acid, methyl succinic acid, chlorogenic acid, oxoadipic acid, and malic acid, with positively higher correlations with all anticancer activities. This comprehensive database of blueberry metabolites along with anticancer activities could be targeted as natural anticancer potentials. This study would be of great value for food, nutraceutical, and pharmaceutical industries as well as plant biotechnologists.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-ND).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.